Gleason 4+3 = 7 скачать в хорошем качестве

Gleason 4+3 = 7

In this video, PCRI's Alex and Medical Oncologist Mark Scholz, MD, discuss the first steps and prognosis for men who have been diagnosed with Gleason 4+3=7, intermediate-risk prostate cancer. 0:07 What is the Gleason score, and what is the difference between Gleason 3+4=7 and 4+3=7? 2:13 Do all pathologists report the newer "Epstein" 1-5 grading system instead of or along with the Gleason score? 2:53 What exactly does it mean to have 4+3 as opposed to 3+4? 3:53 Should men always get second opinions on their pathology reports? 4:47 What are the first steps after being diagnosed with 4+3, intermediate-risk, prostate cancer? 5:55 What are the survival rates for Gleason 4+3 prostate cancer? Don’t know your stage? Take the quiz: Visit http://www.prostatecancerstaging.org To learn more about prostate cancer visit http://www.pcri.org Sign up for our newsletter here to receive the latest updates on prostate cancer and the PCRI: https://pcri.org/join Who we are: The Prostate Cancer Research Institute (PCRI) is a 501(c)(3) not-for-profit organization that is dedicated to helping you research your treatment options. We understand that you have many questions, and we can help you find the answers that are specific to your case. All of our resources are designed by a multidisciplinary team of advocates and expert physicians, for patients. We believe that by educating yourself about the disease, you will have more productive interactions with your medical professionals and receive better individualized care. Feel free to explore our website at pcri.org or contact our free helpline with any questions that you have at pcri.org/helpline. Our Federal Tax ID # is 95-4617875 and qualifies for maximum charitable gift deductions by individual donors. The information on the Prostate Cancer Research Institute's YouTube channel is provided with the understanding that the Institute is not engaged in rendering medical advice or recommendation. The information provided in these videos should not replace consultations with qualified health care professionals to meet your individual medical needs. #ProstateCancer #MarkScholzMD #PCRI